47 related articles for article (PubMed ID: 4047730)
1. Revisiting determinants of prognosis in cutaneous melanoma.
Weiss SA; Hanniford D; Hernando E; Osman I
Cancer; 2015 Dec; 121(23):4108-23. PubMed ID: 26308244
[TBL] [Abstract][Full Text] [Related]
2. Tumor thickness as a prognostic guide to melanoma.
Macht SD
Ann Surg; 1981 Jan; 193(1):121. PubMed ID: 7458444
[No Abstract] [Full Text] [Related]
3. Analysis of the Clinical and Histopathological Patterns of 100 Consecutive Cases of Primary Cutaneous Melanoma and Correlation with Staging.
Nam KW; Bae YC; Bae SH; Song KH; Kim HS; Choi YJ
Arch Plast Surg; 2015 Nov; 42(6):746-52. PubMed ID: 26618123
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide for treatment of brain metastases: A review of 21 clinical trials.
Zhu W; Zhou L; Qian JQ; Qiu TZ; Shu YQ; Liu P
World J Clin Oncol; 2014 Feb; 5(1):19-27. PubMed ID: 24527399
[TBL] [Abstract][Full Text] [Related]
5. Staging and prognosis of cutaneous melanoma.
Dickson PV; Gershenwald JE
Surg Oncol Clin N Am; 2011 Jan; 20(1):1-17. PubMed ID: 21111956
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of aid to diagnosis of pigmented skin lesions in general practice: controlled trial randomised by practice.
English DR; Burton RC; del Mar CB; Donovan RJ; Ireland PD; Emery G
BMJ; 2003 Aug; 327(7411):375. PubMed ID: 12919990
[TBL] [Abstract][Full Text] [Related]
7. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
Cox NH; Aitchison TC; Sirel JM; MacKie RM
Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA).
Gelb AB; Smoller BR; Warnke RA; Picker LJ
Am J Pathol; 1993 May; 142(5):1556-64. PubMed ID: 7684198
[TBL] [Abstract][Full Text] [Related]
9. Tumor thickness is not a prognostic factor in thin melanoma.
Kuehnl-Petzoldt C; Fischer S
Arch Dermatol Res; 1987; 279(7):487-8. PubMed ID: 3435178
[No Abstract] [Full Text] [Related]
10. Missed malignant melanomas.
Gordon LG; Lowry WS
Br Med J (Clin Res Ed); 1986 Jun; 292(6534):1524-5. PubMed ID: 3087501
[No Abstract] [Full Text] [Related]
11. Tumor thickness is not a prognostic factor in thin melanoma.
Jones SK; Pocock PV; Briggs JC
Arch Dermatol Res; 1989; 281(1):81-2. PubMed ID: 2730147
[No Abstract] [Full Text] [Related]
12. Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis.
Williams RA; Rode J; Dhillon AP; Jarvis LR; Skinner JM; Jamal O
J Clin Pathol; 1986 Oct; 39(10):1096-8. PubMed ID: 2431005
[TBL] [Abstract][Full Text] [Related]
13. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
14. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
15. An evidence-based staging system for cutaneous melanoma.
Balch CM; Soong SJ; Atkins MB; Buzaid AC; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
CA Cancer J Clin; 2004; 54(3):131-49; quiz 182-4. PubMed ID: 15195788
[TBL] [Abstract][Full Text] [Related]
16. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
17. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
[TBL] [Abstract][Full Text] [Related]
18. Prognostic histopathological factors in malignant melanoma.
Shaw HM; Balch CM; Soong SJ; Milton GW; McCarthy WH
Pathology; 1985 Apr; 17(2):271-4. PubMed ID: 4047730
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
